First report of the mcr-1 gene in colistin-resistant Klebsiella pneumoniae in a tertiary care hospital in Tunisia

Colistin resistance mediated by mcr genes poses a critical threat to antimicrobial therapy, particularly in multidrug-resistant Klebsiella pneumoniae. While mcr-1 has been previously identified in clinical Escherichia coli in Tunisia, no human clinical K. pneumoniae isolate carrying this gene has been reported to date. This study aims to assess colistin resistance rates in carbapenem-resistant clinical K. pneumoniae isolates, characterize genetic resistance determinants in resistant strains, and screen for the occurrence of the mcr-1 gene. This study was conducted from January to December 2024 at Habib Thameur Hospital, Tunis and investigated colistin resistance among carbapenem-resistant K. pneumoniae isolates. Colistin resistance was assessed via broth microdilution (EUCAST criteria). Resistance genes were detected via multiplex PCR and confirmed via Sanger sequencing. Sequence identity was analysed with BLASTn database. Among the 143 carbapenem-resistant K. pneumoniae isolates, 16 [11.2% (95% CI: 6.5–17.5%)] were colistin resistant. All the isolates were multidrug resistant, with a high prevalence of the blaOXA-48-like (14/16) and blaNDM (11/16) carbapenemase genes and the β-lactamases genes blaCTX-M (14/16) and blaSHV (11/16). Additional resistance determinants included the qnrS (14/16), qnrB (15/16), and 16 S rRNA methylase genes (rmtF, rmtC, and armA). One isolate carried the mcr-1 gene, displaying moderate colistin resistance (MIC: 4 mg/L) and harbouring multiple resistance genes. This study reports the first detection of the mobile colistin resistance gene mcr-1 in a clinical K. pneumoniae isolate in Tunisia. While chromosomal mechanisms remain predominant in colistin-resistant K. pneumoniae in the country, this finding underscores the urgent need for enhanced molecular surveillance and antibiotic stewardship to curb the potential risk for future dissemination of mcr-mediated resistance in North Africa.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2026-05-31
DOI
https://doi.org/10.1186/s12879-026-13562-6
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First report of the mcr-1 gene in colistin-resistant Klebsiella pneumoniae in a tertiary care hospital in Tunisia

Farouk Barguellil, Imene Ouzari, Manel Ennaceur, Sonia Chouaieb et al.
BMC Infectious Diseases
Antibiotic Resistance in Bacteria
article

First report of the mcr-1 gene in colistin-resistant Klebsiella pneumoniae in a tertiary care hospital in Tunisia

Farouk Barguellil, Imene Ouzari, Manel Ennaceur, Sonia Chouaieb, Hamza Ben Mesbeh, Othman Bacha
article en

Abstract

Colistin resistance mediated by mcr genes poses a critical threat to antimicrobial therapy, particularly in multidrug-resistant Klebsiella pneumoniae. While mcr-1 has been previously identified in clinical Escherichia coli in Tunisia, no human clinical K. pneumoniae isolate carrying this gene has been reported to date. This study aims to assess colistin resistance rates in carbapenem-resistant clinical K. pneumoniae isolates, characterize genetic resistance determinants in resistant strains, and screen for the occurrence of the mcr-1 gene. This study was conducted from January to December 2024 at Habib Thameur Hospital, Tunis and investigated colistin resistance among carbapenem-resistant K. pneumoniae isolates. Colistin resistance was assessed via broth microdilution (EUCAST criteria). Resistance genes were detected via multiplex PCR and confirmed via Sanger sequencing. Sequence identity was analysed with BLASTn database. Among the 143 carbapenem-resistant K. pneumoniae isolates, 16 [11.2% (95% CI: 6.5–17.5%)] were colistin resistant. All the isolates were multidrug resistant, with a high prevalence of the blaOXA-48-like (14/16) and blaNDM (11/16) carbapenemase genes and the β-lactamases genes blaCTX-M (14/16) and blaSHV (11/16). Additional resistance determinants included the qnrS (14/16), qnrB (15/16), and 16 S rRNA methylase genes (rmtF, rmtC, and armA). One isolate carried the mcr-1 gene, displaying moderate colistin resistance (MIC: 4 mg/L) and harbouring multiple resistance genes. This study reports the first detection of the mobile colistin resistance gene mcr-1 in a clinical K. pneumoniae isolate in Tunisia. While chromosomal mechanisms remain predominant in colistin-resistant K. pneumoniae in the country, this finding underscores the urgent need for enhanced molecular surveillance and antibiotic stewardship to curb the potential risk for future dissemination of mcr-mediated resistance in North Africa.

BMC Infectious Diseases
Habib hospital Thameur (TN), Military Hospital of Tunis (TN), National Institute of Neurology Mongi-Ben Hamida (TN), Tunis El Manar University (TN)
Good health and well-being
Openalex Percentile: Top 10%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.